TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World

Trial Profile

TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Natalizumab (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Acronyms TYGRIS-ROW
  • Sponsors Biogen
  • Most Recent Events

    • 12 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 16 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 12 May 2009 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top